silybin has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muthumani, M; Prabu, SM | 1 |
| Kolarović, J; Mikov, M; Rašković, A; Stilinović, N; Vasović, V; Vukmirović, S | 1 |
2 other study(ies) available for silybin and Cardiac Diseases
| Article | Year |
|---|---|
Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats.
Topics: Adenosine Triphosphatases; Animals; Antioxidants; Arsenites; Disease Models, Animal; Dyslipidemias; Heart Diseases; Heme Oxygenase (Decyclizing); Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lipids; Mitochondria, Heart; Myocardium; NADPH Oxidases; NF-E2-Related Factor 2; Oxidative Stress; Rats; Silybin; Silymarin; Sodium Compounds | 2014 |
The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiotoxins; Doxorubicin; Heart; Heart Diseases; Liver; Liver Diseases; Male; Myocardium; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Reactive Oxygen Species; Silybin; Silybum marianum; Silymarin | 2011 |